Nada’s research interests include targeted nanomedicine, biopharmaceutics, and precision oncology therapeutics. She is skilled in nanoparticle synthesis, aptamer conjugation, HPLC, confocal microscopy, and in situ/in vitro intestinal modelling, with extensive experience in orthotopic tumor models, cell culture, and clinical pharmacy practice. Nada seeks to leverage her interdisciplinary pharmaceutical expertise and translational perspective toward developing commercially viable precision therapeutics in industry.
For more information, please contact one of our APR.Intern Business Development Managers:
- Justin Mabbutt (VIC & TAS) – j.mabbutt@aprintern.org.au / 0413 050 952
- Mark Ovens (NSW & ACT) – m.ovens@aprintern.org.au / 0400 764 763
- Glen Sheldon – g.sheldon@aprintern.org.au / 0431 832 788
- Michael Valentine (VIC) – m.valentine@aprintern.org.au / 0411 600 063

